Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,333 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN.
Kato T, Hirama H, Mitsuzuka K, Maruyama S, Sasaki H, Saito T, Matsumoto R, Sakamoto S, Sakai Y, Fukuhara H, Naya Y, Tsukino H, Hara I, Ogawa O, Hashine K, Fumimasa F, Yokomizo A, Tohi Y, Kakehi Y, Sugimoto M. Kato T, et al. Among authors: maruyama s. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):666-671. doi: 10.1038/s41391-021-00422-4. Epub 2021 Jul 12. Prostate Cancer Prostatic Dis. 2022. PMID: 34253849
Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study.
Tohi Y, Kato T, Yokomizo A, Mitsuzuka K, Tomida R, Inokuchi J, Matsumoto R, Saito T, Sasaki H, Inoue K, Kinoshita H, Fukuhara H, Maruyama S, Sakamoto S, Tanikawa T, Egawa S, Ichikura H, Abe T, Nakamura M, Kakehi Y, Sugimoto M. Tohi Y, et al. Among authors: maruyama s. Urol Oncol. 2022 Feb;40(2):56.e9-56.e15. doi: 10.1016/j.urolonc.2021.05.003. Epub 2021 Jun 8. Urol Oncol. 2022. PMID: 34112576
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study.
Tohi Y, Kato T, Nakamura M, Matsumoto R, Sasaki H, Mitsuzuka K, Inokuchi J, Hashine K, Yokomizo A, Naito H, Hara I, Kawamura N, Inoue M, Fukuhara H, Maruyama S, Sakamoto S, Saito T, Egawa S, Kakehi Y, Sugimoto M. Tohi Y, et al. Among authors: maruyama s. Int J Clin Oncol. 2022 Jan;27(1):194-201. doi: 10.1007/s10147-021-02041-4. Epub 2021 Oct 2. Int J Clin Oncol. 2022. PMID: 34599725
Impact of adherence to criteria on oncological outcomes of radical prostatectomy in patients opting for active surveillance: data from the PRIAS-JAPAN study.
Tohi Y, Kato T, Miyakawa J, Matsumoto R, Sasaki H, Mitsuzuka K, Inokuchi J, Matsumura M, Yokomizo A, Kinoshita H, Hara I, Kawamura N, Hashimoto K, Inoue M, Teishima J, Kanno H, Fukuhara H, Maruyama S, Sakamoto S, Saito T, Kakehi Y, Sugimoto M. Tohi Y, et al. Among authors: maruyama s. Jpn J Clin Oncol. 2022 Sep 18;52(9):1056-1061. doi: 10.1093/jjco/hyac092. Jpn J Clin Oncol. 2022. PMID: 35662340
[The Development of the Preoperative Nomogram Predicting Major Perioperative Complications after Radical Cystectomy with Ileal Conduit or Orthotopic Neobladder].
Yamada S, Osawa T, Abe T, Takada N, Matsumoto R, Ito Y, Kikuchi H, Miyajima N, Tsuchiya K, Maruyama S, Murai S, Shinohara N. Yamada S, et al. Among authors: maruyama s. Hinyokika Kiyo. 2019 Dec;65(12):495-499. doi: 10.14989/ActaUrolJap_65_12_495. Hinyokika Kiyo. 2019. PMID: 31933333 Free article. Japanese.
Particle therapy for prostate cancer: The past, present and future.
Ishikawa H, Tsuji H, Murayama S, Sugimoto M, Shinohara N, Maruyama S, Murakami M, Shirato H, Sakurai H. Ishikawa H, et al. Among authors: maruyama s. Int J Urol. 2019 Oct;26(10):971-979. doi: 10.1111/iju.14041. Epub 2019 Jul 8. Int J Urol. 2019. PMID: 31284326 Free PMC article. Review.
2,333 results